CPHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
China Pharma Holdings Inc (CPHI) is not a good buy at the moment for a beginner investor with a long-term strategy. The company's financial performance is weak, with declining net income, EPS, and gross margin. The technical indicators do not provide a strong buy signal, and there are no significant positive catalysts or recent news to support a bullish outlook. Additionally, there are no proprietary trading signals or congressional trading data to suggest an imminent opportunity.
The MACD is slightly positive but contracting, indicating weakening momentum. RSI is neutral at 55.413, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 0.554), but the overall price trend is bearish with a significant post-market drop of -9.52%.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Weak financial performance, including a drop in net income, EPS, and gross margin. The stock also experienced a significant post-market decline, indicating bearish sentiment.
In Q4 2025, revenue increased by 8.11% YoY, but net income dropped by -0.19% YoY. EPS fell sharply by -66.04%, and gross margin declined significantly by -186.86%.
No analyst rating or price target data available.
